Dopamine and the pharmacology of schizophrenia: the state of the evidence.
D000661:Amphetamine; D000818:Animals; D001921:Brain / Q000378:metabolism*; D002415:Cats; D002421:Caudate Nucleus / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology; D004285:Dogs; D004298:Dopamine / Q000378:metabolism* / Q000502:physiology; D006220:Haloperidol / Q000494:pharmacology; D000882:Haplorhini; D006801:Humans; D008032:Limbic System / Q000378:metabolism; D009638:Norepinephrine / Q000502:physiology; D010868:Pimozide / Q000494:pharmacology; D011605:Psychoses, Substance-Induced / Q000209:etiology; D051381:Rats; D011955:Receptors, Drug; D012559:Schizophrenia / Q000378:metabolism*; D013045:Species Specificity; D013237:Stereoisomerism; D013239:Stereotyped Behavior / Q000187:drug effects; D013329:Structure-Activity Relationship; D013847:Thiethylperazine / Q000494:pharmacology; D013881:Thioridazine / Q000494:pharmacology
D011955:Receptors, Drug; D010868:Pimozide; D013847:Thiethylperazine; D000661:Amphetamine; D006220:Haloperidol; D013881:Thioridazine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine